Cancer is the second most significant cause of death worldwide, with annual increases in both incidence and mortality.
FREMONT, CA: In-vitro diagnostics is a term that refers to a subset of tests or medical devices that assess specimens obtained from the human body and provide critical information for screening, diagnosis, and therapy.
Early detection via In-vitro diagnostics
In-vitro diagnostics are crucial for clinical decision-making in the screening, diagnosis, and treatment of cancer.
These include cytology, surgical pathology, flow cytometry, and molecular testing. Fluid biomarkers for cancer are proteins or other substances produced in more significant quantities by cancer cells than normal cells. Cancer patients' blood, urine, stool, or other body fluids may include these chemicals. AFP is a hepatocellular cancer screening biomarker. Another example is the FIT used to screen for colorectal cancer. The FIT detects human hemoglobin, indicating GI hemorrhage. Genomic markers such as tumor gene mutations, gene expression patterns, and nongenetic changes in tumor DNA are increasingly used in diagnostic pathology and blood or other fluid tests.
Additionally, IVD testing can provide vital information about a patient's health, such as the likelihood of developing a specific cancer type, the stage, and the possibility of remission after treatment. IVD testing may involve screening for human papillomavirus (HPV), which has been linked to cervical cancer, and detecting the existence of a bcr-abl fusion gene to
